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OBJECTIVE: This prospective study was undertaken to evaluate the role of colour Doppler sonography
in the assessment of prostate carcinoma.
METHODS: Forty consecutive patients who were suspected of having prostate carcinoma with either
raised prostate specific antigen or abnormal digital rectal examination were included in the study.
Transrectal greyscale and colour Doppler sonography of the prostate was performed using a 5–9 MHz
intracavitary probe. Needle biopsies were taken from areas that showed increased flow on colour Doppler.
The results were correlated with the final diagnosis established on histopathological examination.
RESULTS: Comparison of greyscale and colour Doppler sonography showed that the latter is more sensitive
and specific in predicting the malignancy. The statistical parameters of colour Doppler versus greyscale
sonography were: sensitivity 88.23 vs. 73.52, specificity 66.66 vs. 33.33, positive predictive value 93.75 vs. 85.18,
and negative predictive value 50 vs. 22.22, respectively.
CONCLUSION: Colour Doppler and greyscale sonography should be routinely performed to improve
detection of prostate carcinoma and to target the lesion. [Asian J Surg 2008;31(1):16–9]
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Introduction
The prostate gland is the site of two common diseases in
the ageing man, benign prostatic hyperplasia and prostate
cancer. The latter is the sixth most common malignancy
in males over the age of 55 and the second most common
cause of death.1 Clinically, the malignancy is suspected on
abnormal digital rectal examination (DRE) or raised
prostate specific antigen (PSA) levels, but DRE is subjective.
PSA alone has poor sensitivity and specificity in predicting
malignancy, particularly in patients with PSA <20 ng/mL.
Transrectal sonography provides high resolution images
of the prostate. Colour Doppler further helps in the eval-
uation of blood flow through prostatic vessels and has
been described as a means of differentiating malignancy
from benign hyperplasia as microvessel density is higher
in the former. This study evaluated the role of colour
Doppler in the assessment of prostate carcinoma.
Materials and methods
This prospective study included 40 consecutive patients
who were suspected of having prostate carcinoma with
either raised PSA (> 4 ng/mL) or abnormal DRE. First,
transrectal greyscale sonography was performed with the
patient in the left lateral position, using a broadband
5–9 MHz intracavitary probe after covering it with a pro-
tective rubber sheath (condom). Greyscale scanning was
done from the base to the apex of the prostate, as well as
surrounding structures such as the seminal vesicles, urethra
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and rectum to look for areas that appeared suspicious.
This was followed by colour Doppler to assess the flow,
through the entire prostate and suspicious foci. The flow
signals from colour Doppler were evaluated and categorized
into three groups relative to surrounding tissue: increased,
equal, or decreased. Peak systolic velocity (S), end-diastolic
velocity (D) and resistance index (RI) were also calculated:
R1=S – D/S.
Transrectal ultrasound-guided needle biopsies were
performed to obtain two satisfactory core samples using
a core tissue biopsy needle (18-G, 16 cm) from areas that
showed increased flow on colour Doppler in 32 patients
(greyscale sonography showed areas of altered echotexture
in 22 patients and homogeneous echotexture in 10 patients).
Repeat four quadrant biopsies were done in two patients
who had increased flow signals, and biopsies were negative
for malignancy. All eight patients with equivocal flow and
decreased flow signals were subjected to core needle random
quadrant biopsies. As per the standard practice of our
institute, prophylactic antibiotics were not given.
Ultrasound results were correlated with the final diag-
noses established by histopathological examinations.
Results
Prostate carcinoma was proved in 34 (85%) patients and
benign prostatic disease in six (15%) on the basis of his-
topathological examination. Carcinoma was found in 23
of 29 patients with abnormal DRE; in 11 patients with
malignant disease, DRE had been normal. Of the 39
patients with PSA > 4 ng/mL, 34 had carcinoma and five
had benign disease on pathological examination. PSA lev-
els in patients with carcinoma varied from 5.5 to
218 ng/mL. The mean PSA level in patients with carci-
noma was 53 ng/mL, compared to 9.6 ng/mL in patients
with benign disease.
According to transrectal greyscale ultrasound alone,
benign prostatic disease was suspected in 16 patients
because of the homogeneous echotexture of the prostate
without any features of invasion in the surrounding
structures in 14 patients and an isoechoic nodule in the
central zone in two patients. Twelve of the 14 and one of
the two were later diagnosed with carcinoma according to
histopathology. Hypoechoic nodules (mean size, 9 mm;
range, 2–24 mm) in the peripheral zone in 21 patients and
a heterogeneous echotexture of the prostate in three
patients were considered to be suggestive of malignancy
on transrectal ultrasound; 19 of the 21 patients and two
of the three were later shown to have periprostatic invasion
that was positive for carcinoma on biopsy.
On transrectal colour Doppler sonography, the presence
of increased flow signals were considered positive for
malignancy in 32 patients (30 biopsies proved). Decreased
or equivocal flow signals were considered indicative of
benign disease in eight patients (4 turned out to be malig-
nant on biopsy). The spectral analysis of increased flow
signals showed peak systolic velocity ranging from 1.32 cm/s
to 59 cm/s and end-diastolic velocity ranging from 0.9 cm/s
to 27.5 cm/s. In cases with equal or decreased flow, peak
systolic velocity ranged from 10.4 cm/s to 32.5 cm/s and
end-diastolic velocity ranged from 2.1 cm/s to 7.2 cm/s.
Mean RI in the former spectrum was 0.73 and in the latter
was 0.79. The difference in the mean RI between the two
groups was not statistically significant. Table 1 shows
concordance of greyscale and Doppler sonography findings
with histopathology in relation to PSA levels.
Complications after transrectal ultrasound-guided
biopsy occurred in one patient in the form of haematuria
of 1 day’s duration, which did not require any treatment.
Although prophylactic antibiotics were not given, follow-up
urine examination of all patients 1 week later did not show
any pyuria. The comparison of greyscale transrectal sonog-
raphy and colour Doppler sonography with histopa-
thological diagnosis (Table 2) showed that colour Doppler
sonography is more sensitive and specific in predicting
prostate malignancy. The statistical parameters of colour
Doppler versus greyscale sonography are sensitivity 88.23
vs. 73.52, specificity 66.66 vs. 33.33, positive predictive value
93.75 vs. 85.18, and negative predictive value 50 vs. 22.22,
respectively. The concordance of greyscale and Doppler
studies with histopathological diagnosis including both
benign and malignant lesions was 25/40 (62.5%) and 34/40
(85%), respectively.
Discussion
In the present study, greyscale and colour Doppler sonogra-
phy using intracavitary probe via a transrectal route was
evaluated for picking up malignancy in the prostate after
abnormal DRE and elevated PSA levels. On transrectal
greyscale sonography, hypoechoic areas in the peripheral
zone, heterogeneous echotexture and features suggestive
of invasion of the capsule and periprostatic tissues were
found to be useful predictors of malignancy. It must be kept
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in mind that all peripheral nodules need not always be
malignant, as in two cases in the present study.
The incidence of carcinoma appearing as hypoechoic
nodules in the present series (55.88%) is similar to other
studies that reported that more than 50% of carcinomas
are hypoechoic.2–4 The incidence of carcinoma with het-
erogeneous echotexture in this study (6%) is at the lower
end of the reported range for such lesions (2–20%).2,3,5
Normal homogeneous echotexture was seen in 35.2%
of cases of prostate carcinoma, which is comparable to the
reported range of 24–32%.6 The incidence of isoechoic
nodule (1 in this study) and hyperechoic nodule (none in
this study) turning out to be malignant is very low.3,5,7
Subtle hyperechoic areas must be differentiated from
highly echogenic prostatic calculi and corpora amylacea.3
The echogenicity in carcinoma has been reported to be
variable and is co-related with stromal fibrosis/desmopla-
sia.4 The histological grade of the carcinoma may modify
the echogenicity.
Transrectal colour Doppler sonography showed in-
creased flow signals in 32 patients; carcinoma was proved
on biopsy in 30 (88.24%). The reported range of increased
flow signals in prostate malignancy varies from 77% to
100%.4,7–9 Tumour angiogenesis causes increased vascula-
ture, which results in increased flow signals. It has been
suggested that hypervascularity even without focal greyscale
abnormality is highly suspicious and must be subjected to
biopsy.10 In the present study, eight cases of carcinoma were
suspected on colour Doppler imaging only as greyscale
ultrasound had shown a normal homogeneous echo pat-
tern. Similar patterns have been reported by others.9,10
Although quite sensitive, colour Doppler studies do have
limitations. Inflammation enhances blood flow through
the prostate.11 In contrast, desmoplastic reactions oblit-
erate tumour vasculature in carcinoma. In the present study,
four cases did not show increased flow signals, and three
of these demonstrated desmoplastic reaction on histology.
A similar incidence of decreased flow signals in malig-
nancy has been reported by Cho et al.12 Benign cases with
increased flow signals but with homogeneous echo pattern
on greyscale ultrasound were demonstrated to be nonspe-
cific prostatitis and nodular hyperplasia on histopathology.
In this study, there was no statistically significant difference
in mean RI between the benign and prostate carcinoma
groups (0.79 and 0.73, respectively). Similar results have
been reported by others.4,8 An attempt was made in the
present study to compare greyscale and Doppler findings
in relation to PSA levels and pathological diagnoses. Al-
though the sample size was small, the observations suggest
that PSA >20 mg invariably indicates malignancy irrespec-
tive of greyscale and Doppler sonographic findings. Doppler
sonography picked up malignancy in 23 of 26 (88.46%)
compared to 18 of 26 (69.23%) on greyscale sonography.
For transrectal greyscale ultrasound, the sensitivity
and specificity of 73.52% and 33.33% are comparable 
Table 1. Comparison of final histopathology, greyscale and colour Doppler sonographic features
Greyscale (n=40)
Colour Doppler
Increased flow Equivocal/Decreased flow
Benign (16)
Homogeneous echotexture (14) 10 (Ca, 8; B, 2) 4 (all Ca)
Isoechoic nodules in central zone (2) 1 (Ca, 1) 1 (B, 1)
Carcinoma (24)
Heterogeneous echotexture (3) 2 (Ca, 2) 1 (B, 1)
Hypoechoic nodules in peripheral zone (21) 19 (Ca, 19) 2 (B, 2)
Ca= carcinoma; B=benign.
Table 2. Concordance of greyscale and Doppler sonography studies
with histopathology and prostate specific antigen (PSA) levels
PSA, mg Patients, n Greyscale Doppler
0–4 1 B 1 1
>4–10 2 B 1 1
3 Ca 1 3
>10–20 3 B 1 2
5 Ca 3 4
>20 26 Ca 18 23
Ca= carcinoma; B=benign.
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to Kelly et al’s figures of 75% and 49%, respectively.8
The addition of colour Doppler improved the sensitivity
and specificity to 83.33% and 66.66%, respectively, in the
present study, which is almost the same as reported by
others.11,13 The 85% concordance of colour Doppler stud-
ies with histopathological diagnosis is much higher than
the 62.5% concordance of greyscale sonographic findings
with histopathological findings.
In this study, ultrasound-guided transrectal biopsy of
the prostate was done without analgesia, anaesthesia or
prophylactic antibiotics. The complication rate of 2.5%
was negligible and the same as the 2.5% reported by Rifkin
and Choi.14
Colour Doppler sonography should be routinely per-
formed together with greyscale transrectal sonography of
the prostate gland to improve detection and targeting 
of lesions in prostate carcinoma. We further recommend
that even if negative findings are noted on both greyscale
and colour Doppler sonography, ultrasound-guided trans-
rectal biopsy be performed to rule out prostatic malig-
nancy in patients with PSA >4 mg.
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